Iconic Worldwide Bhd (9113) fair value: what the stock is really worth
As of Nov 6, 2026: fair value (intrinsic value) of Iconic Worldwide Bhd stock MYR 0.13, price MYR 0.12, upside +10.0%, quality 58 out of 100. Rating: fairly valued. Calculated from audited financials with 24 of our 26 valuation models and 37 quality factors, updated daily.
69 individual criteria per stock, every one traceableSee the method →
Price vs Fair Value
White line = price, green steps = our fair value per fiscal year. As of Nov 9, 2026.
How to read this chart
60‑month range 0.0600 MYR – 0.4959 MYR · fair‑value band 0.0880 MYR – 0.1760 MYR · the 0.1200 MYR price screens below the 0.1320 MYR fair value. Green steps = our fair value per fiscal year (point-in-time, no hindsight). As of Nov 9, 2026.
Follow Iconic Worldwide Bhd in your weekly email
Every Wednesday you see whether Iconic Worldwide Bhd is on track or worth a review, plus price against fair value. Free, up to 3 stocks.
We send you a confirmation link. Unsubscribe with one click.
Iconic Worldwide Berhad, an investment holding company, engages in tourism and property businesses in Malaysia, Turkey, Hong Kong, Thailand, Philippines, the Middle East Indonesia, Australia, Thailand, and India.
Show moreShow less
It operates through four segments: Property, Manufacturing, Hospitality services, and Others. The company develops and sells residential, commercial properties and undertakes management of car park operations.
It also provides hospitality management and related services; operates as a hotelier; management services for hotels and residences; property investment; and manufactures, distributes, and deals in personal protective equipment products and related appliances, such as disposable face masks and gloves; and personal hygiene, and cosmetics related products.
The company was formerly known as Sanbumi Holdings Berhad and changed its name to Iconic Worldwide Berhad in August 2019. Iconic Worldwide Berhad is based in Bukit Mertajam, Malaysia.
Stock analysis
Iconic Worldwide Bhd (9113) currently trades at 0.1200 MYR, while our model-based Fair Value estimate is 0.1320 MYR, so the stock looks roughly fairly valued today (gap 9.1%).
Show more
Valuation
Bull case: the Growth DCF group reads highest at a median of 0.1200 MYR per share, and 7 of the 24 models we run sit above the 0.1200 MYR price.
Bear case: the Earnings-Based group reads lowest at 0.0500 MYR, and 17 of the 24 models stay below the price. Data coverage for this calculation is low.
Scenario range: 0.0880 MYR (bear) to 0.1760 MYR (bull), the price of 0.1200 MYR sits inside it. Bear and bull are the same models on cautious and optimistic assumptions, a range, not a price target.
Quality & growth
The Quality Score stands at 58/100 (solid quality), in the Healthcare sector.
Mixed Growth: Revenue is growing, but margins or cash flow do not fully confirm the trend.
Iconic Worldwide Bhd reported revenue of 87.6M MYR in FY2026 versus 107M MYR in FY2022, a compound −4.9%/yr. Reported net income was 9.3M MYR in FY2026, compounding −0.6%/yr from FY2022.
Key figures
Market cap 202M MYR (≈ $49.9M) Micro · P/E ratio 12.0 · P/S ratio 1.28 · EPS (TTM) 0.0100 MYR · Net margin 10.7% · Return on equity 5.0% · Return on assets (EBIT) −6.8% (5-year average) · Operating margin 18.4%.
Competitive moat
Our AI-assisted moat analysis scores the competitive advantage at 45 out of 100 (low confidence).
What moves the price
The share trades about 4% below its 52-week high and 100% above its 52-week low, currently above its 200-day average.
For context, the median of 10 Healthcare peers we cover trades at −44% fair-value upside, at 10%, 9113 screens cheaper than that median.
Fair Value models
Bear0.0880 MYRFair Value 0.1320 MYRBull0.1760 MYR
Price 0.1200 MYR · Upside +10.0%
Model ⓘEach model values the company its own way (discounted cash flow, earnings, assets, dividends). The fair value above starts from their evidence-weighted blend, not from a single model. In cyclical trough or peak years, after dilution or a stock split it is adjusted afterwards, so it can sit above or below the models. Based on fiscal year 2026 figures (about 7 months old). Earnings retained since then (0.0061 MYR per share) are deliberately not added.Bear ⓘBear = the cautious scenario: the same model computed with conservative anchors (lower growth, margins and valuation multiples). Together with Bull it frames a plausible valuation range, not a price target.BaseBull ⓘBull = the optimistic scenario: the same model computed with favourable anchors (higher growth, margins and valuation multiples). Together with Bear it frames a plausible valuation range, not a price target. If a model's bull case is above four times its base value, the table shows that limit with a > sign (like the overall Bull above): beyond it no assumption holds.Coverage ⓘCoverage = how well-backed THIS model's estimate is for this stock (0–100): how complete and reliable its input data are, and how well the model fits the company. The final Fair Value is an evidence-weighted blend, so better-evidenced models count more. Green ≥70, amber 50–69, grey below 50.
Growth Quality ⓘGrowth is valuable only when reinvestment earns attractive returns (Aswath Damodaran): sustainable growth depends on return on capital, reinvestment and efficiency. Basis: total company revenue over the periods shown on the cards (3Y/5Y/all years), not per share, so a merger can show up as a growth jump; per-share earnings growth is in the value-creation card.91/100
Revenue is growing, but margins or cash flow do not fully confirm the trend.
Revenue growth 1 year
+84.8%
Revenue growth 3 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+0.3%
Revenue growth 5 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+12.2%
Start year 2021 (pandemic). Over 10 years: +6.4% a year
Revenue growth 13 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+0.0%
’15
’16
’17
’18
’19
’20
’21
’22
’23
’24
’25
’26
What shareholders gained per year (last 5 years), in MYR ⓘWhat the business itself delivers per year: earnings growth per share plus the dividend yield. This is what you get IF the market keeps valuing the stock the same way: it contains no assumption about the market changing its mind. Computed per share, so buybacks count and a merger does not pass as growth. For a company that pays no dividend it is pure earnings growth per share. Period: earnings growth per share as CAGR over the last 5 reported fiscal years (annual statements), plus the current dividend yield. The start value is the median of the three years around the start, so a single crisis year (a pandemic or a write-down) does not distort the rate. Measured in MYR: this currency has depreciated against the euro and dollar over the long run, so part of the nominal rate is currency erosion that never reaches a EUR/USD investor.
−23.4%
Earnings growth per share plus dividend.
Earnings per share, growth per year−23.4%
Dividend (yield on the price)0.0%
Profit margin 2021 to 2026 ⓘOperating margin then vs now, from reported annual statements. A falling margin after a boom year is the classic peak-earnings signal: the growth rate then leans on an inflated base.18% → 10%
⚠ Revenue per share shrinking 21.2%/yr over ~9Y (margin trend unclear) ⓘStructural-decline marker: revenue PER SHARE has fallen over the last decade (robust median trend, not a single year). Backtested across 2005 to 2017, such businesses trailed the market by about 2.5 percentage points per year. Display only: it does not change the fair value or the quality score.
Growth Forecast
Price in line with expectations
The price assumes about as much growth as the company has delivered so far.
What the price assumes ⓘThis turns our valuation around: instead of asking what the share is worth, it asks what growth the current price requires. It uses the cash the company keeps after all spending (free cash flow), the same discount rate as our models, five years of growth, then slowing evenly to 2 % a year by year ten. Compared with the analysts' sales forecasts extended to the same five years (at least three analysts, for context only, it does not enter the Fair Value): within 3 percentage points counts as "in line" (amber), below that little optimism (green), above that a lot of optimism (red).
+9.4%
Yearly growth needed for the next five years to justify today's price.
What forecasts expect
n/a
No analyst forecast available.
After inflation (Malaysia: IMF forecast 2.0% a year to 2030, 1.8% from 2016 to 2025) that is about +7.3% a year for the price.
Price, fair value, quality and upside side by side.
Free, no sign-up
Peer GroupⓘHow this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.Medical Instruments & Supplies · 181 stocks
Beats the industry median on 8/13 measures
Overall it ranks above its industry peers.
Valuation
Quality Score58 · Below median
Fair Value upside+10.0% · Above median
Profitability
Return on equity (12 months)5.0% · Below median
Return on assets2.9% · Below median
Net margin (12 months)10.7% · Above median
Operating margin (12 months)18.4% · Above median
Growth and dividend
Revenue growth (quarter YoY)242.2% · Top 25%
Balance sheet
Debt / equity0.28× · Highest 25%
Valuation Multiplesvs Medical Instruments & Supplies median · lower = cheaper
P/E (12 months)12.0× · Cheapest 25%
P/B1.04× · Cheapest 25%
P/S (12 months)2.31× · Cheaper than median
Price / free cash flow (fiscal year)15.4× · Cheaper than median
For bloggers, editors and developers: paste this into your site or blog (a “Custom HTML” block in WordPress), it shows the current fair value and links back here. Free, plain HTML, and welcome. Full data streams (CSV/JSON) at /developers.
Cite: Fair Value Calculator (2026). "Iconic Worldwide Bhd Fair Value". https://www.fairvalue-calculator.com/stock/9113
Frequently asked questions
Is Iconic Worldwide Bhd (9113) overvalued or undervalued?
As of Nov 9, 2026, our model estimates a fair value of 0.1320 MYR versus a price of 0.1200 MYR, about +10% upside (fairly valued).
What is the fair value of 9113?
Our model-based fair value for Iconic Worldwide Bhd is 0.1320 MYR (as of Nov 9, 2026), built from audited fundamentals. The current price: 0.1200 MYR.
What is the quality score of 9113?
Iconic Worldwide Bhd has a Quality Score of 58/100. It measures business quality (profitability, growth, cash flow, balance-sheet strength, investment discipline, share issuance). Market factors such as price momentum and volatility do not enter the number; they are shown separately in the detail view.
What is the price target for Iconic Worldwide Bhd (9113)?
Our model-based price target is the fair value of 0.1320 MYR (as of Nov 9, 2026) from 24 valuation models. Cautious scenario 0.0880 MYR, optimistic scenario 0.1760 MYR. It is a calculation from audited fundamentals, not an analyst target.
What is the Iconic Worldwide Bhd stock forecast for 2026?
Our models put fair value at 0.1320 MYR, about +10% upside versus a price of 0.1200 MYR (fairly valued). Cautious scenario 0.0880 MYR, optimistic scenario 0.1760 MYR. The calculation is refreshed regularly with new filings.
What is the revenue of Iconic Worldwide Bhd (9113)?
Iconic Worldwide Bhd reported trailing-twelve-month revenue of about 87.6M MYR (latest available figure, as of Nov 9, 2026).
What growth is priced into Iconic Worldwide Bhd (9113)?
For today's price to be fair in a discounted-cash-flow model, Iconic Worldwide Bhd would have to grow free cash flow by +9.4 % per year for five years (discount rate 9.7 %, then slowing evenly to 2 % perpetual growth by year ten). Over the last 5 years revenue grew +12.3 % per year. As of Nov 9, 2026.
What discount rate (WACC) does the fair value of 9113 use?
Our models discount Iconic Worldwide Bhd at 9.7 %: a base by market capitalisation (nano), damped by beta 0.37, country premium for Malaysia. The same rate applies in all 26 models.
What is a reverse DCF?
A reverse DCF turns the usual calculation around. Instead of deriving a value from assumptions, it takes today's price as given and asks: what free-cash-flow growth would a company have to deliver for exactly this price to be fair? The result is not a forecast but the expectation already priced in. For Iconic Worldwide Bhd that is +9.4 % per year for five years, then slowing evenly to 2 % by year ten, using the same discount rate (9.7 %) and the same formula as our fair value.
How much growth has Iconic Worldwide Bhd (9113) delivered so far?
Over the past 5 years revenue at Iconic Worldwide Bhd grew +12.3 % a year. The price currently implies free-cash-flow growth of +9.4 % per year. Comparing the two shows how much confidence is in the price: if it demands more than has been delivered, the business has to accelerate for the maths to work.
How fast is the sector of Iconic Worldwide Bhd (9113) growing?
The median revenue growth in the sector is +4.7 % a year. That is the yardstick for the growth priced into Iconic Worldwide Bhd (+9.4 % per year): it shows whether the expectation is within the usual range or beyond it.
What is the free cash flow yield of Iconic Worldwide Bhd (9113)?
The free-cash-flow yield on the price is 6.48 %: that much free cash flow Iconic Worldwide Bhd produces per unit of market value. When it exceeds the discount rate of our models (9.7 %), the business already earns more than its cost of capital demands, and the price needs little additional growth.
What is the intrinsic value of Iconic Worldwide Bhd (9113)?
Intrinsic value and fair value mean the same thing: what the business is worth on its numbers, independent of the share price. For Iconic Worldwide Bhd it is 0.1320 MYR per share (as of Nov 9, 2026), against a price of 0.1200 MYR. It is the blended result of 24 valuation models in 7 families (DCF Models, Earnings-Based, Multiples, Asset-Based, Growth DCF, Economic Profit, Growth Earnings).
Is Iconic Worldwide Bhd stock overvalued or undervalued in 2026?
As of Nov 9, 2026, 9113 trades below its calculated fair value: price 0.1200 MYR, fair value 0.1320 MYR, a gap of about +10% (fairly valued). The calculation is refreshed with each new quarterly report, so the verdict can change during the year.
Is fair value the same as the market price of 9113?
No. The price is what the market pays today (0.1200 MYR); the fair value is what the company's own numbers justify (0.1320 MYR). For Iconic Worldwide Bhd the two are 0.0120 MYR per share apart. That gap is exactly why we show both numbers side by side.
How much is Iconic Worldwide Bhd worth?
The market values Iconic Worldwide Bhd at about 202M MYR (market capitalisation, as of Nov 9, 2026). Per share that is 0.1200 MYR; our models calculate a fair value of 0.1320 MYR per share.
What do the bullish and bearish scenarios say about 9113?
Our models span a range for Iconic Worldwide Bhd: cautious scenario 0.0880 MYR, base 0.1320 MYR, optimistic 0.1760 MYR per share (as of Nov 9, 2026, price 0.1200 MYR). The range comes from different growth and margin assumptions, not from analyst opinions.
What is the P/E ratio of 9113?
Iconic Worldwide Bhd trades at a price-to-earnings ratio of 12.0 (as of Nov 9, 2026). A P/E on its own says little: it compares the price with ONE year of profit, while our fair value of 0.1320 MYR is built from several models across several years. Other multiples: P/B 1.0, P/S 2.3, EV/EBITDA 25.0.
How solid is the balance sheet of Iconic Worldwide Bhd (9113)?
Balance-sheet figures for Iconic Worldwide Bhd (as of Nov 9, 2026): return on equity 5.0%, debt of 0.28 per unit of equity. They feed the Quality Score of 58/100, which measures business quality independently of the share price.
How far is 9113 from its 52-week high?
Iconic Worldwide Bhd trades at 0.1200 MYR, about 4% below its 52-week high of 0.1250 MYR and 100% above the low of 0.0600 MYR (as of Nov 6, 2026). Distance from the high says nothing about value: that is what the fair value of 0.1320 MYR is for.
Which stocks are comparable to Iconic Worldwide Bhd?
From the same area (Healthcare) we also value Intuitive Surgical, Inc, EssilorLuxottica Société anonyme, Becton, Dickinson and Company, Medline Inc, among others. Each of them has its own fair-value calculation on this site using the same models, so the comparison is like for like.
Is Iconic Worldwide Bhd stock attractive at the current price?
The data as of Nov 9, 2026: price 0.1200 MYR, calculated fair value 0.1320 MYR (+10%), Quality Score 58/100, from 24 models. Whether that fits your horizon and risk tolerance is your call. We provide the calculation, not investment advice.
How is the fair value of 9113 calculated?
We run Iconic Worldwide Bhd through 24 models from 7 families: DCF Models, Earnings-Based, Multiples, Asset-Based, Growth DCF, Economic Profit, Growth Earnings. Every model gets the same audited fundamentals; the fair value of 0.1320 MYR builds on their evidence-weighted average, with the spread shown as a cautious and an optimistic scenario.
Is it still worth investing in stocks now?
The global stock market currently sits 13.3% above its aggregate fair value. Iconic Worldwide Bhd currently trades 9% below its own fair value, and the market average says nothing about that. An expensive market is no reason to stay out and no reason to buy everything at once: keep a broad savings plan running, buy single stocks only with money you can do without, and hold part of your money liquid while the market is high. The full picture including sectors is on is it worth investing now.
What is the share price of Iconic Worldwide Bhd (9113)?
The closing price on Nov 6, 2026 was 0.1200 MYR. Our model-based fair value is 0.1320 MYR, about +10% upside (fairly valued). We carry closing prices from our data provider, not a live tick.
What should I pay attention to with Iconic Worldwide Bhd right now?
The price sits close to our fair value, market and models broadly agree here, little valuation tension. A fairly wide model range (0.0880 MYR to 0.1760 MYR) leaves room in how you read the outcome. Evidence is limited here (fewer models, shorter history), so the fair value is a rougher estimate than usual.
Key figures of Iconic Worldwide Bhd
How large is the market capitalisation of Iconic Worldwide Bhd (9113)?
The market capitalisation of Iconic Worldwide Bhd is 202M MYR (≈ $49.9M). The stock-market value of the whole company: share price times number of shares. It is what the market asks for the entire business today.
What is the P/S ratio of Iconic Worldwide Bhd (9113)?
The price-to-sales ratio of Iconic Worldwide Bhd is 1.28 (P/E × margin). Price to sales: market value relative to yearly revenue. Useful when profit is thin or distorted.
What are the earnings per share of Iconic Worldwide Bhd (9113)?
Earnings per share at Iconic Worldwide Bhd are 0.0100 MYR (price ÷ EPS = P/E 12.0). Earnings per share over the last twelve months: total profit spread across every single share.
What is the net margin of Iconic Worldwide Bhd (9113)?
The net margin of Iconic Worldwide Bhd is 10.7% (fiscal year 2026). How much of every unit of revenue ends up as profit. 10% means 10 cents of profit per dollar of sales.
What is the return on equity of Iconic Worldwide Bhd (9113)?
The return on equity (ROE) of Iconic Worldwide Bhd is 5.0% (last twelve months). Profit relative to shareholders' equity, how efficiently the company works with its owners' money.
What is the EBIT return on assets of Iconic Worldwide Bhd (9113)?
On an EBIT basis the return on assets of Iconic Worldwide Bhd is −6.8% (avg 5y). Operating profit (EBIT) relative to everything the company owns, as a multi-year average. It describes the business model rather than one good or bad year.
What is the operating margin of Iconic Worldwide Bhd (9113)?
The operating margin of Iconic Worldwide Bhd is 18.4% (last twelve months). Profit from the core business (before interest and taxes) relative to revenue.
How fast is revenue growing at Iconic Worldwide Bhd (9113)?
Revenue at Iconic Worldwide Bhd is growing +242% versus a year earlier (3y avg +0.3%). How much revenue grew versus a year earlier (YoY). The 3-year average next to it puts the single year in context.
How fast are earnings growing at Iconic Worldwide Bhd (9113)?
Earnings per share at Iconic Worldwide Bhd are growing +664% versus a year earlier. How much earnings per share grew versus a year earlier.
How much net debt does Iconic Worldwide Bhd (9113) carry?
The net debt of Iconic Worldwide Bhd is 69.7M MYR (fiscal year 2026, ≈ 5.3 yrs of FCF). Debt minus cash on hand. The note shows how many years of free cash flow could in theory pay it off.
Free · no account needed
Watch Iconic Worldwide Bhd in the live analysis
One click puts Iconic Worldwide Bhd on your watchlist: fair value and trend at a glance, plus comparison, the diversification check and the 27,000+ stock screener.
Thin data
Nov 9, 2026